EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...
Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing ...
The Closure Compiler is a tool for making JavaScript download and run faster. It is a true compiler for JavaScript. Instead of compiling from a source language to machine code, it compiles from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果